Books:

Flow Cytometry of Hematological Malignancies [Hardcover] 
Claudio Ortolani (Author)

it was released on 15th July 2011.

 

Cellular Diagnostics-basic principles, 
methods and applications of flow cytometry

Editors: Ulrich Sack, Attila Tárnok, Gregor Rothe

 

Articles:

1: Richards SJ. Introduction to ICCS/ESCCA consensus guidelines to detect

GPI-deficient cells in paroxysmal nocturnal hemoglobinuria and related disorders.

Cytometry B Clin Cytom. 2018 Jan;94(1):12-13. doi: 10.1002/cyto.b.21617. PubMed

PMID: 29389086.

 

2: Preffer F. Special Issue: Updated ICCS/ESCCA PNH guidelines. Cytometry B Clin

Cytom. 2018 Jan;94(1):11. doi: 10.1002/cyto.b.21616. PubMed PMID: 29389084.

 

3: Oldaker T, Whitby L, Saber M, Holden J, Wallace PK, Litwin V. ICCS/ESCCA

consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal

hemoglobinuria (PNH) and related disorders part 4 - assay validation and quality

assurance. Cytometry B Clin Cytom. 2018 Jan;94(1):67-81. doi:

10.1002/cyto.b.21615. PubMed PMID: 29251828.

 

4: Sutherland DR, Illingworth A, Marinov I, Ortiz F, Andreasen J, Payne D,

Wallace PK, Keeney M. ICCS/ESCCA consensus guidelines to detect GPI-deficient

cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders part 2 -

reagent selection and assay optimization for high-sensitivity testing. Cytometry

B Clin Cytom. 2018 Jan;94(1):23-48. doi: 10.1002/cyto.b.21610. PubMed PMID:

29236353.

 

5: Dezern AE, Borowitz MJ. ICCS/ESCCA consensus guidelines to detect

GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related

disorders part 1 - clinical utility. Cytometry B Clin Cytom. 2018

Jan;94(1):16-22. doi: 10.1002/cyto.b.21608. PubMed PMID: 29236352.

 

6: Illingworth A, Marinov I, Sutherland DR, Wagner-Ballon O, DelVecchio L.

ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal

nocturnal hemoglobinuria (PNH) and related disorders part 3 - data analysis,

reporting and case studies. Cytometry B Clin Cytom. 2018 Jan;94(1):49-66. doi:

10.1002/cyto.b.21609. PubMed PMID: 29236350.

 

7: Rawstron AC, Kreuzer KA, Soosapilla A, Spacek M, Stehlikova O, Gambell P,

McIver-Brown N, Villamor N, Psarra K, Arroz M, Milani R, de la Serna J, Cedena

MT, Jaksic O, Nomdedeu J, Moreno C, Rigolin GM, Cuneo A, Johansen P, Johnsen HE,

Rosenquist R, Niemann CU, Kern W, Westerman D, Trneny M, Mulligan S, Doubek M,

Pospisilova S, Hillmen P, Oscier D, Hallek M, Ghia P, Montserrat E. Reproducible

diagnosis of chronic lymphocytic leukemia by flow cytometry: An European Research

Initiative on CLL (ERIC) & European Society for Clinical Cell Analysis (ESCCA)

Harmonisation project. Cytometry B Clin Cytom. 2018 Jan;94(1):121-128. doi:

10.1002/cyto.b.21595. Epub 2018 Jan 17. PubMed PMID: 29024461; PubMed Central

PMCID: PMC5817234.

 

8: Lambert C, Preijers FWMB, Yanikkaya Demirel G, Sack U. Monocytes and

macrophages in flow: an ESCCA initiative on advanced analyses of monocyte lineage

using flow cytometry. Cytometry B Clin Cytom. 2017 May;92(3):180-188. doi:

10.1002/cyto.b.21280. Epub 2015 Dec 12. PubMed PMID: 26332381.

 

9: Rawstron AC, Paiva B, Stetler-Stevenson M. Assessment of minimal residual

disease in myeloma and the need for a consensus approach. Cytometry B Clin Cytom.

2016 Jan;90(1):21-5. doi: 10.1002/cyto.b.21272. Epub 2015 Sep 23. PubMed PMID:

26202864.